BBS-Bioactive Bone Substitutes PLC Ordinary Shares BONEH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.48
- Day Range
- €0.47–0.48
- 52-Week Range
- €0.36–0.92
- Bid/Ask
- €0.47 / €0.48
- Market Cap
- €8.80 Mil
- Volume/Avg
- 16,290 / 32,218
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BBS-Bioactive Bone Substitutes PLC) is a biomedical technology company that develops, manufactures, and commercializes innovative, bioactive medical devices and implants for orthopaedic surgery, and develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 21
- Website
- https://www.bbs-artebone.fi
Valuation
|
Metric
|
BONEH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.81 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BONEH
Financial Strength
|
Metric
|
BONEH
|
|---|---|
Quick Ratio | 1.47 |
Current Ratio | 1.47 |
Interest Coverage | −28.78 |
Quick Ratio
BONEH
Profitability
|
Metric
|
BONEH
|
|---|---|
Return on Assets (Normalized) | −32.63% |
Return on Equity (Normalized) | −76.06% |
Return on Invested Capital (Normalized) | −33.08% |
Return on Assets
BONEH
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fsxhkmvf | Mjgcj | $185.4 Bil | |
SYK
| Stryker Corp | Bqgvxrhfm | Bjncy | $128.2 Bil | |
BSX
| Boston Scientific Corp | Mhgbntp | Cqgnsng | $107.7 Bil | |
MDT
| Medtronic PLC | Vbcjhmqf | Nqcbmy | $105.2 Bil | |
DXCM
| DexCom Inc | Xqntpxdl | Ghvm | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Tsynsywmty | Hvqdvr | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wyggvxfhw | Wcvn | $24.6 Bil | |
ALGN
| Align Technology Inc | Czkhnrn | Fjrdvd | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Tsxrptmc | Khscmhv | $19.0 Bil | |
PODD
| Insulet Corp | Hklrtqgcz | Ttdpvkc | $11.5 Bil |